Skip to content

Clinical trials

Phase 2 Liver Cirrhosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 2 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20122
20131
20151
20161
20171
20181
20191
20223
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated6
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Gilead Sciences3
Sanofi3
Boehringer Ingelheim1
Celgene1
Dr. Falk Pharma GmbH1
European Foundation for Study of Chronic Liver Failure1
Galmed Research and Development, Ltd.1
GlaxoSmithKline1
Histogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis19
Non-alcoholic Fatty Liver Disease10
Fibrosis4
Ascites3
Liver Diseases3
Fatty Liver2
Hypertension, Portal2
Acute-On-Chronic Liver Failure1
Cholangitis, Sclerosing1
Diabetes Mellitus1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.